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ABSTRACT 
 
In addition to coupling mechanically to produce movement, the musculoskeletal unit has 
an endocrine function, capable of signaling to distant tissues as well as locally through the 
release of hormone-like molecules.  Musculoskeletal disuse triggers loss of bone and 
skeletal muscle function while exercise improves musculoskeletal health and protects 
against chronic disease. We investigated potential crosstalk pathways within the 
musculoskeletal unit involving, (1) muscle derived BAIBA in muscle-to-bone crosstalk and 
(2) bone MBTPS1 in bone-to-muscle crosstalk. To assess the impact of BAIBA on muscle 
and bone properties, mice were immobilized for two weeks via hind limb suspension while 
receiving L-BAIBA. Fast twitch extensor digitorum longus (EDL) muscles and slow twitch 
soleus muscles were then isolated for ex vivo contractility testing and tibia was obtained 
for analysis of trabecular bone content.  In muscle, L-BAIBA supplementation showed no 
effect on muscle mass or EDL contractile function but increased slow-twitch soleus 
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contractile force by 15% over non-supplemented mice.  In addition, the rate of soleus 
muscle contractile force development was greater in the supplemented group compared to 
control. In bone, L-BAIBA receiving mice had higher tibia BV/TV compared to control.  Next, 
we investigated the role of Mbtps1 in bone-to-muscle crosstalk using osteocyte-specific 
Mbtps1 conditional knock-out mouse (cKO) using Dmp1-driven Cre.  MBTPS1 is a widely 
expressed proprotein convertase involved in proprotein processing within the secretory 
pathway. In bone, MBTPS1 is required for normal skeletal development and mineralization. 
Ex vivo contractility of cKO EDL and soleus muscles revealed an age-related enhancement 
of slow-twitch soleus muscle contractile force, muscle size and regeneration of slow type-1 
muscle fibers compared to control littermates while EDL muscle properties remained 
largely unaffected. Subsequent gene array analysis uncovered upregulation of genes 
related to muscle contraction, oxidative metabolism and muscle regeneration in the cKO 
soleus. These findings reveal possible targeted impacts of musculoskeletal auto-, para-, and 
endocrine signaling among slow twitch skeletal muscle and support the novel paradigm of 
relevant musculoskeletal crosstalk axes in the maintenance of muscle and bone health. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
Skeletal Muscle Heterogeneity 
 
The musculoskeletal unit plays dual roles in providing the mechanical components 
for physical activity as well as functioning as an endocrine organ regulating distant and 
local tissue physiology.  Skeletal muscles comprise the largest organ system in the body 
with each muscle constituting a mosaic of different myofiber types with distinct mechanical 
and metabolic properties, the relative proportions of which equate to a specific whole 
muscle functional output.  The relationship of muscle fiber type and contractile function 
was initially described in frog (Rana pipiens & R. catesbiana) in the 1950’s where it was 
observed that certain fiber populations displayed “tonic” or rapid contractile responses 
while other fibers showed a “phasic” or prolonged contractile response to nerve 
stimulation (1). Subsequent studies provided the physiological evidence to suggest that 
sarcomeric myosin, the molecular motor underlying contraction, existed as several 
isoforms confined to specific fiber types within muscle (2, 3) and that contractile force and 
shortening velocity directly correlated with the distinct myosin heavy chain (MHC) isoform 
expression profiles (4). Among these, MHC type 1 (MHC1) expressing fibers or “slow 
twitch” fibers display reduced contractile force and slower shortening velocity relative to 
MHC type 2 (MHC2) enriched or “fast twitch” fibers.  The contribution of the MHC isoforms 
to muscle contraction velocity is attributed to rate of ADP release from the MHC-ATPase 
catalytic domain during the power stroke step of the cross bridge cycle. MHC1 exhibits the 
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lowest rate of ADP dissociation relative to MHC2 isoforms which increase in release rate in 
order from MHC2a2x2b (5).  Additional fiber-type specific myofibrillar and calcium 
handling protein isoforms that  contribute to a fast or slow myofiber phenotype include 
fast/slow myosin light chain isoforms and phosphorylation state (6), troponin, tropomyosin 
and sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) (7).  
Muscle fiber types may be further subcategorized with respect to metabolic 
character. These subcategories include slow twitch oxidative (e.g. Soleus muscle), fast 
twitch oxidative (e.g. Semitendinosus muscle) or fast twitch glycolytic muscles (e.g. 
Extensor digitorum longus muscle).  Oxidative muscles harbor abundant mitochondria, 
increased vascularization and a higher content of the O2 binding protein myoglobin, 
conferring the advantage of increased resistance to muscle fatigue during endurance 
activity (8). In addition to generating mobility, muscle contraction also plays an important 
role in the regulation of bone physiology. 
 
Muscle-Bone Interaction 
 
Mechanosensation and Transduction 
 
The intimate and co-regulatory relationship of skeletal muscle and bone beyond the 
manifestation of physical movement has been known for quite some time wherein physical 
load placed on bone related to muscle contractile forces, serves as a signal to which the 
main resident cells of mineralized bone, the osteocytes, are able to sense and respond by 
modulation of bone architecture and mass (9).  Osteocytes reside within cavities 
embedded in the mineralized bone matrix, termed lacunae, which provide the osteocyte 
with oxygen and nutrients via a network of small canals linked to the vasculature and other 
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osteocyte lacunae called the lacunar-canalicular system (10). There is evidence to suggest 
that osteocytes sense mechanical loading through the shear stress produced by movement 
of the surrounding canalicular fluid triggering an anabolic paracrine response within bone. 
This response is characterized by initial release of bone anabolic mediator molecules from 
osteocytes including ATP, nitric oxide (NO) and prostaglandin E2 (PGE2) which may also 
travel to neighboring osteocytes through gap junctions or be secreted into the bone fluid 
(11, 12).  
 
Musculoskeletal Unloading/Disuse 
 
Lack of applied load on bone such as with prolonged inactivity of muscle during bed 
rest or in a microgravity environment such as space flight, results in dramatic alterations in 
the structure and function of the musculoskeletal unit.  The response to reduced loading in 
bone leads to a compromised ability to form new bone and increases bone resorption 
activity of osteoclasts, equating to a total net loss of cortical and trabecular bone content 
and diminished bone strength (13, 14). In the case of muscle, disuse triggers significant 
muscle atrophy, reduced muscle fiber cross sectional area (CSA), and lowered muscle 
contractile force and fatigue resistance.  The adaptive response to unloading manifests 
chiefly and initially and in the slow twitch muscles like the soleus (14-16), while 
predominately fast twitch muscles such as the extensor digitorum longus (EDL) muscle 
tend to resist this transformation (15).   The adaptation of slow twitch muscles to disuse is 
underscored by the modification of muscle fiber type and metabolic homeostasis  including 
a shift in MHC composition from the slower type 1 to faster type 2 MHC isoforms (17) 
concomitant with the degradation of oxidative metabolic capacity.  Mitochondrial 
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dynamics and function show a compromised fate following muscle disuse highlighted by a 
reduction in mitochondrial biogenesis (18, 19), altered mitochondrial morphology (20), and 
lowered respiratory potential (21, 22).  The physiological response of the musculoskeletal 
unit to extended physical inactivity not only impacts the quality of muscle and bone but  is 
also associated with an increased risk for the development of chronic diseases such as 
obesity, type II diabetes mellitus, cardiovascular disease and cancer (23, 24).  It is becoming 
more apparent that the influence of muscle activity and exercise on long term systemic 
health outcomes may therefore rely on alternate avenues of communication consisting of 
biochemical and hormonal interaction among muscle and distant organs.  
 
Skeletal Muscle as a Secretory Organ 
 
The discovery that skeletal muscles function as a secretory organ by releasing 
signaling molecules (termed “myokines” by the Pederson laboratory) in response to exercise 
(25) and that these factors may confer health benefits has sparked great interest from a 
therapeutic perspective (26). Myokines may exert their effects in an auto-, para- or 
endocrine manner within the body. The foremost identified and utmost studied myokine is 
Interluekin-6 (IL-6).  Originally observed to increase 100-fold in plasma  following muscular 
exercise (27), IL-6 release and signaling is independent of contraction-induced muscle 
damage (28, 29) and has been shown to offer protection against obesity and type 2 diabetes 
by enhancing fatty acid oxidation and glucose uptake in local muscle beds (30) and distant 
organs such as adipose tissue (27) and liver (31) via an AMP-activated protein kinase (AMPK) 
mediated pathway. In contrast to the pro-inflammatory response associated with IL-6 
release from circulating immune cells like monocytes, IL-6 derived from muscle activity 
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actually leads to increased content of circulating anti-inflammatory interleukin1 receptor 
antagonist (IL-1ra) and IL-10 which ease whole-body inflammation after a single bout of 
exercise (32, 33). Additional interleukin-type myokines discovered to date include IL-7, 8, 
and 15 which are involved in diverse adaptive processes such as angiogenesis (34, 35) 
myogenic differentiation (36) and muscle hypertrophy (37). Interestingly, overproduction of 
muscle IL-15 in transgenic mice led to augmented bone mineral density (38). Further 
evidence suggests the existence of additional and important endocrine communication axes 
between skeletal muscle and bone.   
Additional myokines so far identified and associated with effects in bone include 
myostatin and irisin. Myostatin, a member of the TGF-β superfamily is synthesized and 
released into the circulation by muscle where it primarily acts locally as a negative regulator 
of muscle mass. Circulating myostatin levels have been observed to be inversely associated 
with bone mineral density and bone content in rodents and humans (39). Next, the exercise-
induced peptide myokine irisin, is currently the focus of considerable research for its 
potential in treatment/prevention of metabolic diseases.  Irisin is the cleavage product of 
the myo-membrane protein fibronectin type III domain containing peptide 5 (FNDC5) which 
is secreted into the vasculature in a pattern dependent upon the exercise response master 
transcriptional regulator, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-
1α) (40). Irisin alters metabolic homeostasis through stimulation of fatty acid β-oxidation and 
induction of a brown fat-like phenotype in white adipose tissue through upregulation of 
genes involved in thermogenesis like uncoupling protein 1 (Ucp1) (41). In bone, irisin has 
been demonstrated to produce anabolic effects on cortical bone formation by driving 
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expression of key osteogenic genes such as Runx2, Osx, and β-catenin while downregulating 
the osteogenic inhibitor, Sost (42, 43). Secreted metabolic regulatory factors such as irisin 
may form a crucial endocrine crosstalk pathway linking muscle and bone health.  The newly 
identified small molecule exercise factor, β-aminoisobutyric acid (BAIBA) has been found to 
modulate systemic energy homeostasis in response to exercise and may also mediate the 
positive effects of exercise on the musculoskeletal unit. 
 
β-aminoisobutyric Acid (BAIBA): A Metabolite Exercise Factor 
 
BAIBA is a non-proteinogenic β-amino acid produced during catabolism of thymine 
and valine.  BAIBA was initially observed to exert reducing effects on body adiposity which 
stemmed from the observation that certain thymine analogue antiretroviral reverse 
transcriptase inhibitors (stavudine, zidovudine) induced significant fat wasting in mice 
leading to a significant reduction in fat mass while lean mass remained unaltered (44). 
Upon evaluation of the catabolites of these drugs, BAIBA was found to recapitulate the fat 
wasting effects by reducing body adiposity through enhancing hepatic mitochondrial fatty 
acid oxidation and downregulating de novo lipidogenesis in normal and obese mice (44, 45) 
suggesting an exciting new potential as an anti-obesity treatment.   A recent study utilizing 
a metabolic profiling technique to identify novel muscle secreted metabolites participating 
in exercise-related tissue crosstalk, identified an enrichment of BAIBA in conditioned media 
from myocytes overexpressing PGC-1α (46). The authors went on to show that following 
wheel running exercise in mice, serum levels of BAIBA were increased. Furthermore, 
application of BAIBA to isolated primary inguinal adipocytes and in vivo showed an increase 
in expression of the brown adipose specific genes, cell death inducing DFA like effector A 
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(Cidea) and Ucp1, and also enhanced cellular respiration and glucose uptake (46). BAIBA 
has also been demonstrated to attenuate insulin resistance, alleviate hepatic steatosis and 
reduce hepatic endoplasmic reticulum (ER) stress and apoptosis in a mouse model for type 
II diabetes (47). Moreover, in skeletal muscle BAIBA administration reversed 
hyperlipidemic-induced insulin intolerance through AMPK-PPARδ mediated pathway and 
suppressed inflammation by inhibiting nuclear factor κβ (NFκβ) translocation and 
downstream inflammatory cytokines (48). Indeed, BAIBA-mediated crosstalk pathways 
harbor potential as treatment targets for metabolic disorders, however it is unknown 
whether BAIBA may offer similar benefits in the treatment of musculoskeletal diseases 
such as sarcopenia and osteoporosis. 
 
Bone as a Secretory Organ 
 
Having established a role of skeletal muscle in inter-tissue biochemical 
communication we now turn to skeletal bone, specifically the main resident cells of bone, 
osteocytes, and their role in endo-, para-, autocrine signaling. Osteocytes have historically 
been perceived as passive entities buried deep within the mineralized tissue of bone. 
However, only recently has the dynamic secretory/endocrine nature of these 
multifunctional cells and their key involvement in local and non-bone tissue regulation 
been appreciated (49, 50). Osteocytes are indispensable for the coordination of bone 
remodeling processes in response to mechanical load through the regulation of both 
osteoclast and osteoblast activity. As aforementioned, mechanical strain placed upon bone 
induces the rapid synthesis and release of NO and PGE2 from osteocytes. These secreted 
factors act to support bone formation by promoting osteoblast differentiation and reducing 
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proliferative activity (51-53).  Osteocytes also secrete several direct inhibitors of bone 
formation, namely SOST (54), DKK1 (55) and SFRP1 (56) which disrupt the Wnt/β-catenin 
signaling pathway important for bone anabolism. Osteoclasts are the chief resorbing cells 
within bone and are activated upon stimulation of receptor-activator of nuclear factor κβ 
(RANK) through RANK ligand (RANKL). Expression of RANKL has been detected in 
osteocytes (57) as well as the osteoclast-inducing macrophage colony-stimulating factor 
(M-CSF) (57) and decoy receptor osteoprotegerin, implicating osteocytes as crucial 
directors on bone resorption. Osteocytes coordinate with distant tissues such as with the 
renal system to regulate serum phosphate levels through the actions of osteocyte-derived 
circulating fibroblast growth factor 23 (FGF23) (58). Circulating FGF23 downregulates 
sodium/phosphate co-transporters in kidney leading to increased serum phosphate. 
Interestingly, chronically elevated FGF23 may lead to pathology such as chronic kidney 
disease, hypo-phosphatemic rickets and even cardiovascular dysfunction (59-63).    
Osteocyte-derived factors may also have important implications for skeletal muscle health 
and homeostasis. Osteocyte/osteoblast-specific deletion of connexin43 led to impaired 
postnatal muscle development and reduced strength in mice possibly involving circulating 
osteocalcin (64). Mo and colleagues showed that muscle cells co-cultured with conditioned 
media from osteocytes or with PGE2 developed into larger myotubes and showed 
upregulation of key genes involved in myogenic differentiation, mitochondrial homeostasis 
and intracellular calcium handling (65).  Clearly, muscle and bone are in conversation. 
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The Proprotein Convertase MBTPS1 
 
Subilisin/kexin isozyme-1 (MBTPS1, SKI-1, S1P) is a widely expressed serine protease 
belonging to the family of proprotein convertases (PC) which function in proprotein 
processing within the secretory pathway of cells (66). PCs cleave within specific amino acid 
consensus sequences in diverse substrates molecules such as prohormones, pro-cytokines 
and pathogens converting them into biologically active/inactive forms (67, 68). MBTPS1 is 
mainly localized to the cis/medial Golgi compartment and specifically cleaves peptides at 
non-basic consensus sequences containing serine, threonine or leucine residues (69). 
MBTPS1 has been shown to enzymatically regulate membrane cholesterol content through 
cleavage of sterol regulatory element binding proteins (SREBPs) (70) as well as regulate 
cAMP response element-binding protein (CREB) (71) activity. In bone, MBTPS1 is required 
for normal skeletal development and ossification (72) as loss of function of MBTPS1 results 
in phenotypic abnormalities to sacral/lumbar vertebrae form and quantity resembling 
caudal regression syndrome (73). Moreover, osteoblast-directed bone mineralization in 
vitro is dependent upon SK1-1 activity through regulation of mineralization and matrix-
related genes, Phex, Dmp1, fibronectin, tenascin, fibrillin, Col11a1 and Col1a2 by MBTPS1-
activated transcription factors SERBP and CREB/ATF (74, 75). These results firmly establish 
a fundamental role for MBTPS1 in the proper development of functional bone. 
In summary, based on the secretory role for muscle and bone beyond mechanical 
interaction, we chose to investigate two potential crosstalk pathways between muscles and 
bone that of the muscle factor BAIBA and the bone protease, MBTPS1. Firstly, the muscle 
derived exercise factor, BAIBA, displays autocrine/paracrine and endocrine effects in 
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muscle, adipose and liver tissues with the potential to treat metabolic disease, however 
the actions of BAIBA on skeletal muscle contractile function and bone architecture remains 
to be established. Utilizing a mouse hind limb suspension approach as a model of 
prolonged hind limb unloading/disuse we hypothesized that BAIBA supplementation would 
serve as an endogenous exercise signal and attenuate disuse-related muscle and bone 
functional and structural decline through improvement of contractile force and 
fatigueability of fast and slow twitch skeletal muscle and reduction of trabecular bone 
volume loss. We show that supplementation of L-BAIBA within this context resulted in 
improved sub-maximal contractile force in slow twitch soleus muscle and increased 
trabecular bone volume. Secondly, we investigated the role of the protease, MBTPS1 in 
bone-muscle crosstalk. Since MBTPS1 is required for proper processing and release of 
secreted peptides necessary for bone mineralization, we investigated whether the 
conditional deletion in vivo in the late embedding osteocyte through a Dmp1-cre X 
Mbtps1fl/fl driven system in 3-month and 10-12 month-old mice would impact skeletal 
muscle functional properties and size involving a similar secretory mechanism. Here we 
provide compelling evidence that MBTPS1 mediates a bone-to-muscle crosstalk pathway 
through repression of myogenesis since its conditional deletion in osteocytes resulted in a 
slow-twitch muscle-specific increase in soleus muscle mass, contractile force and actively 
regenerating slow-twitch muscle fibers with age (76). 
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CHAPTER 2 
 
METHODOLOGY 
 
 
BAIBA Study 
Muscle Conditioned Media (MCM) 
 
Intact EDL and soleus muscles were dissected from 5-month old male and female 
C57BL/6 mice and stimulated to contract ex vivo as previously described (77, 78). Briefly, 
dissected muscles were ligated via the tendons inside glass chambers containing Ringer’s 
solution. To produce static MCM, muscles were maintained in buffer without contraction 
for 30 minutes after which point the Ringer’s solution was collected and replaced with 
fresh solution. A length-force relationship was then employed to determine optimal length 
at which maximal force is achieved. Muscles were equilibrated for 30 min to mimic 
conditions of normal activity. Following equilibration, muscles were stimulated with 
frequencies ranging from 1–130 Hz to generate the force versus frequency relationship and 
to determine the frequency producing maximal force. The bathing solution was then 
removed and muscles were rinsed with fresh solution to eliminate factors released during 
the mounting and stretching procedure. To create contracted MCM, muscles were 
stimulated to contract with a 90Hz stimulus repeated every minute (non-fatiguing) for 30 
min after which period the bathing solution was collected.  
Quantitation of BAIBA Isomers in MCM 
1 ml of MCM containing 3 ml of 10mM D-alanine were concentrated by freeze dry 
and resolved in 50 ml of A buffer (HPLC-grade water/0.1% Formic Acid). Marfey’s 
  12   
 
derivatization was performed as described previously with slight modifications (79, 80). 
Briefly, 20 ml of the resolved pellet was derivatized with 20 ml of 40mM Marfey reagent 
(Sigma-Aldrich) and 5 ml of 1M triethylammonium (TEA, Sigma-Aldrich) by incubation at 37C 
for 2.5 hrs. 5 ml of 1M HCl and 150 ml of B buffer (HPLC-grade water/25% Acetonitrile/0.2% 
Formic Acid) were added to quench the reaction and then analyzed by liquid 
chromatography-mass spectrometry (LC/MS). Chromatographic separations were 
performed on a Nucleodur 100-3 C8 column 125 x 2 mm (Macherey–Nagel, Bethlehem, PA) 
at with flow rate of 0.3 mL/min. The mobile phases consisted of A – water/0.1 % formic acid, 
B – 70/30/0.1 % acetonitrile/water/formic acid, C – acetonitrile/0.1 % formic acid. Two 
gradients were used in this study. The long gradient consists of 25 % B for 5 min, 25-42.5 % 
B over 35 min, 42.5- 25 %B over 1 min, and a post run equilibration time for 4 min. For short 
method, isocratic 42.5 %B is ran for 15min with a quick wash with 100 %B for 1 min followed 
by post –equilibrium to 42.5 % B. The long method is to ensure all the BAIBA isomers are 
separated and short method is to perform quick analysis of muscle CM. Mass spectrometry 
quantitation was performed using selection reaction monitoring (SRM) detection in positive 
mode for Marfey’s derivatized BAIBA isomers. The Q1 (parent mass) is 356.2 m/z with 
fragment masses (Q3) 266.2, 311.2, 192.2. The Q3 192.2 ion is the differentiating signal 
between BAIBA and GABA where the signal is intense for BAIBA and very less for GABA and 
used for BAIBA analysis in muscle CM and serum samples. Performed by Dr. Yukiko Kitase. 
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Hind limb Unloading 
 
All experimental procedures were approved by the Institutional Animal Care & Use 
Committees at the University of Missouri Kansas City (Kansas City, MO, USA). 5-month-old 
male C57BL/6 mice were randomly divided into two groups consisting of a hind limb 
suspended (HS) group with L-BAIBA (n=6 mice) and a HS group without L-BAIBA (n=6 mice). 
During the HS protocol hind limbs were suspended off the ground for 14 days via tail ring 
inserted between caudal vertebrae and attached to the top of the cage. Suspended mice 
had full range of motion on front limbs and ad libitum access to food and normal water 
(n=6) or water supplemented with L-BAIBA (n=6). L-BAIBA was dissolved in drinking water at 
a concentration of 100mg/kg/day and drinking water was replaced freshly each day.  
Performed by Dr. Yukiko Kitase. 
Ex Vivo Muscle Contractility at Physiological Temperature 
 
Mice were sacrificed by cervical dislocation and the EDL and soleus muscles were 
removed for contractility analysis as previously described (78).  Muscles were immediately 
placed into a dish containing a physiological buffer solution (118 mM NaCl; 5 mM KCl; 1 
mM MgCl2; 1 mM NaH2PO4; 25 mM NaHCO3; 2.5 mM CaCl2; pH 7.40) with 10 mM glucose. 
This solution was continuously aerated with a 95/5% O2/CO2 mixture.  EDL and soleus 
muscles were mounted vertically between two stimulating platinum electrodes and 
proximal and distal tendons were secured to adjustable isometric force transducers and to 
a fixed support, respectively.  The muscles were immersed into 20 ml bathing chambers 
containing physiological buffer maintained at 37°C by a heated water circulating pump. 
PowerLab® Software (ADInstruments Inc., Colorado Springs, CO, USA) was used to store 
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and analyze force data. Stimulatory voltage was provided by a S88X dual pulse digital 
stimulator (Grass Products, West Warwick, RI, USA) (pulse duration, 1 ms; train duration, 
500 ms). Muscles were lengthened until a single tetanus stimulation produced maximal 
force and remained at this optimal muscle length (L0) for the duration of the experiment.  
Equilibration: EDL and soleus muscles were next allowed a 30 minute equilibration period 
during which time they were stimulated with intercalating high and low frequency pulse-
trains spaced every 3 min which corresponded to maximal (Tmax) and half maximal (½ Tmax) 
isometric force, respectively (200/100Hz for EDL; 160/40Hz for soleus).  The proposed 
stimulation protocol aids with the study of the relative contributions of the contractile 
proteins (Tmax) and the sarcoplasmic reticulum (½ Tmax) to contractile function (81).  Force-
Frequency Relationship: Following equilibration, the EDL and soleus muscles were 
stimulated to contract with frequencies ranging from 1-220 Hz with a periodicity of 3 min 
to generate the force vs. frequency (FF) relationship. Zero External Calcium: Following FF, 
muscles were allowed to contract at Tmax and ½ Tmax at which point the physiological buffer 
in the chambers was changed to one which did not contain Ca2+ but instead 0.1 mM EGTA. 
Muscles were contracted for 30 min at Tmax and ½ Tmax with a rest interval of 3 min in order 
to assess dependence of muscle contractility on extracellular Ca2+.  Recovery from Zero 
Calcium: The physiological buffer was then replaced with the buffer containing 2.5 mM 
Ca2+ and muscles were allowed 30 min of contractions at Tmax and ½ Tmax with a periodicity 
of 3 min.   Fatigue:  Next, to induce fatigue, the EDL and soleus muscles were stimulated at 
Tmax and ½ Tmax with a periodicity of 2 seconds for 5 minutes.   Recovery from Fatigue: 
Immediately following the fatiguing protocol, the EDL and soleus muscles were allowed 30 
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min recovery period during which time they were stimulated at Tmax and ½ Tmax with a 
periodicity of 3 min. Recovery with Caffeine: The muscles were then allowed a second 
similar 30 min recovery period with 5mM caffeine added to the chamber bath to gauge 
overall EC coupling during the recovery period.  After the experiment, the L0 of each muscle 
was measured and muscles were excised at their myotendonous junctions, blotted dry and 
weighed.  Force Data: Muscle force is reported as absolute force (mN).   Slope Data: The 
slope of the rising edge of muscle contractions was measured 0-31 ms after the start of the 
peak. Tau Data: Tau was calculated from 90%-0% of peak height during the relaxation 
phase of muscle contractions. All data is presented as mean ± SEM. 
 
Ex Vivo Microcomputed Tomography (µCT)  
 
Right leg tibiae were dissected and fixed for 1 day in 4% paraformaldehyde, and 
then kept in 70% ethanol at 4°C until use. Specimens were scanned at 55 kV, 145 µA, high 
resolution, 10.5 mm voxel, 200 ms integration time. Three-dimensional images 
reconstructed within the range of 1 mm from the most proximal metaphysis of tibiae were 
analyzed. Trabecular morphometry was studied by excluding the cortical bone from the 
endocortical borders using hand drawn contours followed by thresholding, and was 
characterized with bone volume fraction (BV/TV). Performed by Dr. Yukiko Kitase. 
 
MBTPS1 Study 
 
Dmp1-cre Mbtps1 cKO Mice 
 
Animals were maintained in the University of Missouri-Kansas City Laboratory 
Animal Research Center under an approved protocol. Mbtps1-floxed mice were obtained 
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from Dr. Jay Horton, Southwest Medical School and Dr. Linda Sandell, Washington 
University (82); Dmp1-cre mice were obtained from Dr. Lynda Bonewald, University of 
Missouri-Kansas City (83). Males (Mbtps1 flx/+):Dmp1(cre/+)) were crossed with females 
(Mbtps1(flx/flx)) to obtain Mbtps1cKO mice (Mbtps1(flx/flx):Dmp1(cre/+)) offspring; this 
strategy deletes exon 2 of the Mbtps1 gene and should be effective in ablating expression 
of all expressed forms containing the catalytic site. Only male Mbtps1 cKO (Mbtps1(flx/flx) 
× Dmp1-cre(+/−)) and control mice (Mbtps1(flx/flx)) were used here to limit the study size 
and the effects of the estrous cycle. Mice were maintained on standard mouse chow with 
free access to food and water and housed in ventilated cages with filter bonnets in rooms 
with a regulated 12-h light and 12-h dark cycle. Offspring were found to be viable 
throughout the pregnancy and postnatal period. Phenotypic characteristics for 12-week-
old, and 40-week-old mice were based on observations of Mbtps1 cKO mice along with a 
comparable number of control littermates.  
 
Ex Vivo Muscle Contractility at Room Temperature 
 
Mice were sacrificed by cervical dislocation and the EDL and soleus muscles were 
removed for contractility analysis as previously described (78).  Muscles were immediately 
placed into a dish containing a physiological buffer solution (142 mM NaCl; 5 mM KCl; 1.8 
mM MgCl2; 10 mM HEPES; 2.5 mM CaCl2; pH 7.40) with 10 mM glucose, continuously 
aerated with 100% O2.  EDL and soleus muscles were mounted vertically between two 
stimulating platinum electrodes and proximal and distal tendons were secured to 
adjustable isometric force transducers and to a fixed support, respectively.  The muscles 
were immersed into 20 ml bathing chambers containing physiological buffer and 
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experiments were performed at room temperature. PowerLab® Software (ADInstruments 
Inc., Colorado Springs, CO, USA) was used to store and analyze force data. Stimulatory 
voltage was provided by a S88 dual pulse digital stimulator (Grass Products, West Warwick, 
RI, USA) (pulse duration, 1 ms; train duration, 500 ms). Muscles were first lengthened until 
a single tetanus stimulation produced maximal force and muscles remained at this optimal 
length (L0) for the duration of the experiment.  Equilibration: EDL and soleus muscles were 
next allowed a 30 minute equilibration period during which time they were stimulated with 
high frequency pulse trains which corresponded to maximal (Tmax) isometric force.  Force-
Frequency Relationship: Following equilibration, the EDL and soleus muscles were 
stimulated to contract with frequencies ranging from 1-130 Hz with a periodicity of 1 min 
to generate the force vs. frequency (FF) relationship. Zero External Calcium: Following FF, 
muscles were allowed to contract at Tmax to ensure that the preparation was stable at 
which point the physiological buffer in the chambers was changed to one which did not 
contain Ca2+ but instead 0.1 mM EGTA. Muscles were contracted for 20 min at Tmax with an 
interval of 1 min in order to assess dependence of muscle contractility on extracellular 
Ca2+.  Recovery from Zero Calcium: The physiological buffer was then replaced with the 
buffer containing 2.5 mM Ca2+ and muscles were allowed 30 min of contractions at Tmax 
with a periodicity of 1 min.   Fatigue:  Next, to induce fatigue, the EDL and soleus muscles 
were stimulated with at Tmax with a periodicity of 1 second for 5 minutes.   Recovery from 
Fatigue: Immediately following the fatiguing protocol, the EDL and soleus muscles were 
allowed 30 min recovery period during which time they were stimulated at Tmax with a 
periodicity of 1 min. Recovery with Caffeine: The muscles were then allowed a second 
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similar 30 min recovery period with 5mM caffeine added to the chamber bath to gauge 
overall EC coupling during the recovery period.  After the experiment, the L0 of each muscle 
was measured and muscles were excised at their myotendonous junctions, blotted dry and 
weighed.  Force Data: Muscle force is reported as absolute force (mN) and force 
normalized to muscle physiological cross sectional area (N/cm2) as previously reported 
(78).  All data is presented as mean ± SEM. 
Immunohistochemistry of Muscle Cryosections 
Soleus muscles and extensor digitorum longus muscles (EDL) were dissected 
immediately after sacrifice and flash frozen in optimum cutting temperature medium for 
storage. Muscles were cut into 14-μm-thick sections using a cryostat and then processed 
for immunofluorescence staining using a protocol adapted from that published by Phillips 
et al. (84). Briefly, sections were air-dried, acetone-fixed, and then blocked with mouse 
M.O.M. IgG blocking reagent (Vector Laboratories, Inc.) for 1 h at room temperature. After 
washing in PBS, sections were incubated overnight in the following mixture of primary 
antibodies dissolved in PBS containing 2% normal goat serum: 1:100 anti-type 1 myosin 
heavy chain (BS.D5 IgG2b, Developmental Studies Hybridoma Bank), 1:200 anti-type IIA 
myosin heavy chain (SC.71 IgG1, Developmental Studies Hybridoma Bank), and 1:100 anti-
type IIB myosin heavy chain (BF.F3 IgM, Developmental Studies Hybridoma Bank). After 
washing in PBS, sections were treated for 2 h with the following mixture of secondary 
antibodies dissolved in PBS containing 2% normal goat serum: Alexa Fluor 647-conjugated 
goat anti-mouse IgG2b (Invitrogen), Alexa Fluor 488-conjugated goat anti-mouse IgG1 
(Invitrogen), and Alexa Fluor 594-conjugated goat anti-mouse IgM (Invitrogen). After 
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washing extensively with PBS, sections were post-fixed in methanol for 5 min, rinsed in 
PBS, and then cover-slipped with mounting medium including DAPI (Vector Laboratories, 
Inc.). Sections were imaged using an inverted Nikon TE2000-E epifluorescence microscope 
and Metamorph software. ImageJ software was used to overlay different colored images of 
the same field, and then contrast and brightness were adjusted in Photoshop. Performed 
by Dr. Jeffery Gorski. 
 
Muscle RNA Isolation and Processing for Whole Genome Array 
 
Total RNA was isolated from flash frozen cKO and control soleus muscle samples 
(n=3 mice per group) using an RNeasy Micro kit according to standard protocols along with 
the inclusion of a proteinase K digestion step. The RNA was analyzed for quality using a 
Nanodrop and an Agilent Bioanalyzer after which 100 ng of total RNA were used for the 
Agilent Mouse Transcriptome Array 1.0 protocol. Briefly, the total RNA was primed with 
primers containing a T7 promoter sequence. Single-stranded cDNA was synthesized with a 
T7 promoter sequence at the 5′-end, converted to double-stranded cDNA, and in vitro 
transcribed with T7 RNA polymerase to generate antisense RNA. The cRNA was cleaned up 
using a bead protocol and then used to synthesize sense strand cDNA in a reaction that 
included dUTP at a fixed ratio relative to dTTP. RNase H was used to hydrolyze the cRNA 
strand after which the sense strand cDNA was purified using beads and then fragmented at 
the unnatural dUTP residues using uracil-DNA glycosylase and apurinic/apyrimidinic 
endonuclease 1. The fragmented cDNA was labeled by terminal 
deoxynucleotidyltransferase using the Affymetrix proprietary DNA Labeling Reagent that is 
covalently linked to biotin. The biotinylated and fragmented cDNA was hybridized 
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overnight to the Mouse Transcriptome 1.0 arrays after which it was washed and stained on 
a FS450 GeneChip system and scanned using a GCS30007G scanner.  
The CEL files from muscle or bone osteocytes then were analyzed using Affymetrix 
Expression Console and Transcriptome Analysis Console 2.0. For detailed statistical 
analysis, the CEL files were imported into GeneSpring v13, quantile-normalized using the 
PLIER16 algorithm, and baseline-transformed to the median of all samples. The log2-
normalized signal values were then filtered to remove entities that showed signal in the 
bottom 20th percentile across all samples. The above lists were subjected to a t test (P< 
0.05) with a Benjamini-Hochberg false discovery rate correction. Performed by Dr. Jeffery 
Gorski. 
 
Statistics 
 
Data was statistically analyzed with either two-tailed independent samples t-test for 
single comparisons or with one-way ANOVA followed by Tukey for multiple comparisons 
with p<0.05 considered the threshold for significance.  Normality of the data was assessed 
with Shapiro-Wilks test and homogeneity of variances was determined using Levene’s test.   
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CHAPTER 3 
 
RESULTS 
 
 
BAIBA Study 
 
L-BAIBA but Not D-BAIBA is Released from Isolated Contracting Skeletal Muscles 
 
In order to directly measure isomeric composition of BAIBA released from skeletal 
muscles during contractile activity we choose to isolate whole intact slow-twitch (soleus) 
and fast-twitch (EDL) skeletal muscle groups from healthy adult mice for the generation of 
conditioned media through an established ex vivo muscle contraction protocol (Illustration 
1). As the neuronal components required for contraction are removed from the muscles 
during the dissection process we can directly manipulate muscle contractile output in this 
setup through controlled supply of electrical stimulation.  We detected an approximately 5-
fold increase in the concentration of BAIBA in the MCM from actively contracting muscles 
relative to inactive/static muscle preparations (P<0.05) (Illustration 2). Additionally, LC/MS 
analysis of the preferred isomeric state of muscle-released BAIBA revealed that the L-form 
and not the D-form of BAIBA is exclusively jettisoned from skeletal muscle during ex vivo 
contraction (Illustration 2).  We did not detect any statistical difference (P>0.05) in BAIBA 
release properties between the chosen representative slow-twitch soleus and fast-twitch 
EDL muscles or among males and females (Illustration 2). 
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Illustration 1. Ex vivo Contractility Methodology. Left: Photographs showing protocol for 
EDL and soleus muscle dissection and mounting to the ex vivo contractility system for 
contractile force measurements. Right: Representative raw force data from an entire 
contractility assay. 
 
 
 
 
 
 
 
Illustration 2. LC/MS Quantification of L-BAIBA in MCM.  L-BAIBA was quantified in MCM 
by LC/MS from static (non-contracted) or contracted EDL and soleus muscles isolated from 
hind limbs of wild type, 5-month-old C57BL6 mice. *P<0.05 vs corresponding non-
contracted muscle. Data provided by Dr. Yukiko Kitase. 
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L-BAIBA Supplementation Maintains Contractile Force in Soleus Muscles During 
Unloading   
 
Based on the LC/MS analysis of secreted BAIBA isomers from muscle we 
supplemented mice with 100mg/kg/day of L-BAIBA during a 2 week bout of hind limb 
unloading to probe for a potential therapeutic utility in protecting against muscle structural 
and functional deterioration during sustained disuse. EDL and soleus muscles were 
dissected from L-BAIBA supplemented and non-supplemented mice after the unloading 
period for ex vivo contractility testing and morphometric analysis.  Included in the 
contractility analysis were 6 mice per group, with 12 EDL muscles and 12 soleus muscles 
analyzed per group (muscles from both hind limbs per mouse were tested).  Representative 
data from a contractility experiment are shown in Illustration 1. At the end of 14 days of 
hind limb unloading, soleus muscle morphometric properties including wet weight and 
optimal length showed no differences across the control and L-BAIBA treated groups 
(Illustration 3A-B, P>0.05, n=6 mice per group). Analysis of the force-frequency relationship 
in the isolated muscles showed no relative shifts in the relative soleus muscle frequency-
dependent force production among groups (Illustration 3C).  Evaluation of isometric force 
production from L-BAIBA supplemented muscles revealed a 15% increase in soleus muscle 
submaximal force generation (40 Hz stimulation frequency, corresponding to approx. half 
of the maximal force generating capacity (½ Tmax)), (80.1 mN ± 3.0 mN vs. 69.7 mN ± 3.6 
mN, P<0.05, n=6 mice per group) while maximal force generation was not significantly 
altered compared to soleus muscles from control mice (Illustration 3D-E).  We next 
analyzed kinetic properties of individual muscle submaximal and maximal contractions 
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including the rate of force development of the muscle contraction (dF/dt) and rate of 
relaxation (Tau).   The rate, or slope, of force development at ½ Tmax in the soleus muscles 
from the L-BAIBA supplemented group was significantly elevated by 16% compared to 
control (0.309 mN/ms ± 0.014 mN/ms vs 0.267 mN/ms ± 0.011 mN/ms, P<0.05, n=6 mice 
per group) (Illustration 3F-G). The rate of submaximal and maximal force relaxation was 
similar among soleus (Illustration 3H-I) muscles from supplemented and non-
supplemented groups. On the other hand, no statistically significant effects of L-BAIBA 
supplementation were found in the EDL muscles with regard to muscle size and contractile 
force properties (Illustration 4A-H).  
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Illustration 3. Ex Vivo Contractility of Hind Limb Suspended Soleus Muscle. A) Soleus 
muscle optimal length. B) Soleus muscle mass. C) Force-frequency relationship of soleus 
muscle stimulated with frequencies ranging from 1-220Hz. D) Raw data trace of soleus 
muscle 1/2 Tmax contraction (40Hz) and bar graph comparison (inset) from L-BAIBA and 
control groups.  E) Raw data trace of soleus muscle Tmax contraction (140-160Hz) and bar 
graph comparison (inset) between groups. F) Slope of soleus muscle 1/2 Tmax contraction 
(40Hz). G) Slope of soleus muscle Tmax contraction (140-160Hz). H) Soleus muscle 
relaxation (Tau) of 1/2 Tmax contraction (40Hz). I) Soleus muscle relaxation (Tau) of Tmax 
contraction. N=6 mice per group, * denotes p<0.05 versus control group. 
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Illustration 4. Ex Vivo Contractility of Hind Limb Suspended EDL Muscle. A) EDL muscle 
mass. B) EDL muscle 1/2 Tmax (100Hz stimulation frequency). C) EDL muscle Tmax (200Hz 
stimulation frequency). D) Force-frequency relationship of EDL muscle stimulated with 
frequencies ranging from 1-220Hz. E) Slope of EDL muscle 1/2 Tmax contraction. F) Slope of 
EDL muscle Tmax contraction. G) EDL muscle relaxation (Tau) of 1/2 Tmax. H) EDL muscle 
relaxation (Tau) of Tmax. I) EDL muscle force generation after replacement of bathing 
solution with solution devoid of Ca2+ and instead containing 0.1 mM EGTA and after 
reintroduction of 2.5 mM Ca2+ at Tmax and (J) 1/2 Tmax. Data is expressed as a percentage 
of force just prior to removal of external calcium. K) EDL muscle fatigueability, recovery 
from fatigue and response to 5mM caffeine at Tmax and (L) 1/2 Tmax. Expressed as a 
percentage of force just before fatigue. N=6 mice per group. 
 
L-BAIBA Does Not Affect Muscle Dependence on Extracellular Ca2+ or Fatigue/Recovery 
from Fatigue 
 
We also investigated the dependence on extracellular calcium and fatigue 
resistance and recovery from fatiguing contractions in both EDL and soleus muscles. 
Maximal and submaximal force generation from L-BAIBA supplemented and non-treated 
suspended muscles showed indistinguishable force production profiles upon depletion of 
external calcium and after reintroduction of 2.5 mM calcium to the bathing buffer 
(Illustration 4I-J and 5A-B). It has been shown that hind limb unloading in mice results in 
deficiencies to muscle fatigue resistance and force recovery following muscle fatigue (19).  
Muscle fatigueability at maximal or submaximal force and recovery after fatigue in the 
absence and presence of caffeine, which effectively releases calcium from the sarcoplasmic 
reticulum (SR), showed no significant difference between groups (Illustration 4K-L and 5C-
D). 
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Illustration 5. Soleus Muscle Dependence on External Ca2+ and Fatigue/Recovery 
Properties. Soleus muscle force generation after replacement of bathing solution with 
solution devoid of Ca2+ and instead containing 0.1 mM EGTA and after reintroduction of 2.5 
mM Ca2+ at Tmax (A) and 1/2 Tmax (B). Data is expressed as a percentage of force just prior 
to removal of external calcium. Soleus muscle fatigueability, recovery from fatigue and 
response to 5mM caffeine at Tmax (C) and 1/2 Tmax (D) expressed as a percentage of force 
just before fatigue. N=6 mice per group. 
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Preserved Tibial Trabecular Bone Volume in Mice Supplemented With L-BAIBA 
 
A hallmark of the removal of weight bearing load on skeletal bone is a marked 
reduction in trabecular bone volume fraction (BV/TV) which is associated with 
compromised bone structural integrity (85).  In a study performed in parallel with the 
muscle function characterization, we measured trabecular bone content in L-BAIBA 
supplemented and control mice through analysis of BV/TV in whole tibiae via ex vivo µCT 
imaging.  We found that trabecular BV/TV was statistically significantly increased in the 
tibiae from the L-BAIBA treated group over control group (Illustration 6) indicating that 
bone loss was spared with L-BAIBA treatment during hind limb unloading. 
 
 
 
 
 
Illustration 6.  Bone Content of Hind Limb Suspended Mice. Trabecular bone volume 
fraction (BV/TV) of right side tibiae from mice treated with L-BAIBA or non-treated mice 
after 2 weeks of hind limb unloading as determined by ex vivo µCT.  *P<0.05 vs control 
mice. Data provided by Dr. Yukiko Kitase 
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MBTPS1 Study 
 
Soleus Muscles but Not EDL Muscles from Adult Mbtps1 cKO Mice Are Larger and 
Produce More Contractile Force 
 
We assessed the size and ex vivo contractile properties of isolated EDL and soleus 
muscle from 10 month old Mbtps1 cKO mice and age matched control littermates. A 
representative image of the ex vivo contractility protocol is shown in Illustration 7A. Soleus 
muscles from Mbtps1 cKO mice but not EDL muscles were larger than muscles from control 
animals (10.5 mg ± 0.4 mg vs 9.3 mg ± 0.4 mg, P<0.05, n=5 mice per group) (Illustration 7B).  
Not only were the soleus muscles larger in the cKO, but they displayed a 30% increase in 
absolute contractile force and force normalized to muscle physiological CSA (P<0.05) 
(Illustration 7C-E). Interestingly, when similar contractile characterization was carried out 
on EDL muscles, there were no significant differences observed between Mbtps1 cKO and 
control mice (P>0.05) (Illustration 7F-G). 
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Illustration 7. Muscle Size and Contractile Force of 10 Month-Old Mbtps1 cKO Mice. a) 
Representative data obtained from individual muscles during the ex vivo contractility assay. 
Intact EDL and soleus muscles were mounted between two platinum electrodes and 
stimulated with non-tetanic and tetanic voltage trains to induce muscle contraction (y axis, 
contractile force; x axis, time.)  b) EDL and soleus muscle mass from control and Mbtps1 
cKO mice. c) Individual contractions of submaximal (left) and maximal (right) tetanic 
contractions of intact soleus muscles from control (grey line) and Mbtps1 cKO (black line) 
mice stimulated ex vivo. d) soleus muscle absolute contractile force from control mice and 
Mbtps1 cKO mice at increasing frequencies of stimulation in the range of 1–130 Hz. e) 
soleus muscle contractile forces from d normalized to cross-sectional area of the muscle 
(newtons (N)/cm2). f) Absolute contractile force (millinewtons) of intact EDL muscles from 
control and Mbtps1 cKO mice stimulated at frequencies of 1–130 Hz. g) EDL muscle forces 
from f normalized to muscle cross-sectional area (newtons/cm2). Data are represented as 
mean ± SEM. * denotes significant difference (P < 0.05) when compared with control, n=5 
mice per group. 
 
Soleus Muscles from Adult Mbtps1 cKO Mice Display Rightward Shift of the Force-
Frequency Relationship 
 
The force-frequency relationship of soleus muscles from 10 month old adult Mbtps1 
cKO mice showed a significant shift to the right at several submaximal frequencies of 
stimulation (P<0.05, n=5 mice per group) (Illustration 8A).  This shift indicated that higher 
frequencies of stimulation were required in soleus from the Mbtps1 cKO to elicit the same 
amount of contractile force in the soleus muscle from control littermates. Soleus muscle 
fatigue, recovery from fatigue and caffeine response properties were not statistically 
different among cKO and control groups (Illustration 8B).  We also examined the effect of 
removal and subsequent reintroduction of calcium to the bathing buffer on force 
production and observed a similar response between groups (Illustration 8C).  The EDL 
muscles from Mbtps1 cKO mice did not display any shifts in the force-frequency 
relationship or differences in fatigueability/recovery post fatigue or response to removal 
and re-addition of extracellular calcium to the bathing solution (Illustration 8D-F). 
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Illustration 7. Contractile Properties of 10 Month-Old Mbtps1 cKO Mice. a) Force versus 
frequency relationship of soleus muscles from control and Mbtps1 cKO mice stimulated 
with frequencies ranging from 1 to 130 Hz. Force is expressed as a percentage of maximum 
muscle force (Tmax). b) Fatigueability of soleus muscles from control and Mbtps1 mice and 
recovery of force during a period of non-fatiguing tetanic stimulations in both the absence 
and presence of 5 mm caffeine. Data are expressed as a percentage of force produced by 
the muscle prior to fatigue. c) Dependence on external calcium for force production of 
soleus muscles from control and Mbtps1 cKO mice contracted under external conditions of 
0 [Ca2+]o and after replenishment of 2.5 mm [Ca2+]o for force recovery. Data are expressed 
as a percentage of force produced by the muscle prior to removal of [Ca2+]o. d) EDL muscle 
force versus frequency (1–130 Hz) relationship from control and Mbtps1 cKO mice. Force is 
expressed as a percentage of maximum muscle force (Tmax). e) Fatigueability of EDL muscle 
from control and Mbtps1 mice and force recovery after a period of non-fatiguing tetanic 
stimulations in both the absence and presence of 5 mm caffeine. Data are expressed as a 
percentage of force produced by the muscle prior to fatigue. f) Dependence on external 
calcium for force production of EDL muscle from control and Mbtps1 mice contracted in 
external conditions of 0 [Ca2+]o and after washout with 2.5 mm [Ca2+]o for force recovery. 
Data are expressed as a percentage of force produced by the muscle prior to removal of 
[Ca2+]o. Data are represented as mean ± SEM. * denotes significant difference (p < 0.05) 
when compared with control, n=5 mice per group. 
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Type 1 Myosin Heavy Chain-Expressing cKO Soleus Muscle Myofibers Exhibit Centralized 
Nuclei  
 
In order to investigate phenotypic changes at the myofiber level, 
immunohistochemistry was carried out on cryosections of soleus muscles from 10 month 
old Mbtps1 cKO and control mice. DAPI staining (yellow) revealed a 700% increase in the 
amount of centralized nuclei within cKO myofibers compared to control, a characteristic of 
active muscle generation (21.5% ± 5.7% vs 3.5% ± 2.9%, mean ± SD, P<0.05.) (Illustration 9).  
Furthermore, muscle cross sections were fiber-typed through immunostaining for specific 
MHC type 1 and type 2 isoforms. Fiber-typing showed that the central nuclei phenotype 
within cKO soleus muscles occurred specifically in MHC type 1 expressing myofibers while 
neighbouring MHC type 2-containing cells were unaffected an exhibited normal levels of 
central nuclei (Illustration 9). Conversely, EDL muscle cryosections were indistinguishable 
among cKO and control with respect to centralized nuclei content (Data not shown).  
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Illustration 9. Immunostaining of Soleus Cryosections.  Muscles from adult Dmp1-cre 
Mbtps1 cKO and control mice were dissected immediately following euthanasia and flash 
frozen, cryosectioned and immunostained as described under “Experimental Procedures.” 
Images of whole muscle cross-sections were pseudocolored using ImageJ. Magenta-colored 
myofibers: cKO soleus muscle is enriched in type 1 myosin heavy chain-expressing cells 
(magenta-colored myofibers) with centralized nuclei (white arrows), whereas type 1 
myosin heavy chain-positive and type IIA heavy chain-positive (green-colored myofibers) 
control cells contain only background levels of centralized nuclei. Nuclei were identified by 
DAPI staining (yellow color). a)  Control soleus muscle; b) Dmp1-cre Mbtps1 cKO muscle. 
Images shown were photographed at 10× magnification.  Data provided by Dr. Jeff Gorski. 
 
Contractile Properties of Soleus and EDL Muscles from 3-Month Old Mbtps1 cKO Mice 
  
Mbtps1 cKO mice show an increase in body mass occurring abruptly at around 15-
20 weeks of age that persists throughout maturation (data not shown). In order to 
determine if the phenotypic changes observed in the soleus muscles of 10-12 month old 
Mbtps1 cKO mice was related to changes observed in body mass, we performed 
contractility analysis on isolated EDL and soleus muscles from young cKO mice aged to 3 
months, which is just prior to the point at which cKO begin to accumulate body mass. 
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Unlike their mature adult counterparts, young cKO soleus muscle mass, contractile 
strength, and force-frequency response was not significantly different compared to control 
mice (Illustration 10A-B, D-E). Examination of muscle fatigue and recovery also showed no 
change in soleus or EDL muscles among cKO and control groups. Interestingly, EDL muscles 
from young cKO mice produced about 25% more specific force normalized to muscle CSA 
than controls which was not detected in EDL muscles from the mature adult Mbtps1 cKO 
mice (Illustration 10H, P<0.05, n=5 mice per group). 
 
 
 
 
  37   
 
Illustration 10. Contractile Properties of 3 Month-Old Mbtps1 cKO Mice.  a) EDL and 
soleus muscle wet weights from control and Mbtps1 cKO mice. b) Force versus frequency 
curves of intact soleus muscles from control and Mbtps1 cKO mice stimulated at individual 
frequencies ranging from 1 to 130 Hz. Force is normalized to maximum muscle force (Tmax) 
and expressed as a percentage. c) EDL muscle force versus frequency (1–130 Hz) curves 
from control and Mbtps1 cKO mice. Contraction force is normalized to Tmax of the muscle 
and expressed as a percentage. d) Soleus muscle contractile force (millinewtons (mN)) 
from control mice and Mbtps1 cKO mice at increasing frequencies of stimulation in the 
range of 1–130 Hz. e) Soleus muscle contractile forces from d normalized to cross-sectional 
area of the muscle (newtons (N)/cm2). f) Relative contractile force of soleus muscles from 
control and Mbtps1 cKO mice after a fatigue-inducing stimulation protocol and after a 
recovery period of non-fatiguing tetanic stimulations in both the absence and presence of 5 
mm caffeine. Data are expressed as a percentage of force produced by the muscle prior to 
fatigue. g) Contractile force (millinewtons) of intact EDL muscles from control and Mbtps1 
cKO mice stimulated at frequencies of 1–130 Hz. h) EDL muscle forces from g normalized to 
muscle cross-sectional area (newtons/cm2). i) EDL muscle relative contractile force from 
control and Mbtps1 cKO mice after a fatigue-inducing stimulation protocol and after a 
recovery period of non-fatiguing tetanic stimulations in both the absence and presence of 5 
mm caffeine. Data are expressed as a percentage of force produced by the muscle prior to 
fatigue. Data are represented as mean ± SEM. * denotes significant difference (p < 0.05) 
when compared with control, n=6 control mice and n=4 cKO mice. 
 
Whole Genome Array of cKO Soleus Muscles Provides Clues for Increased Performance  
 
To identify possible candidate mechanisms responsible for augmented cKO soleus 
muscle performance and morphometric measures we performed whole genome arrays on 
soleus muscles isolated from 10-month old cKO and control mice (NCBI accession number 
GSE69985).  cKO soleus muscles exhibited significant alterations in expression patterns of 
various genes involved with muscle contraction, oxidative metabolism, and muscle 
myogenesis and regeneration.  Specifically, myofibrillar and sacromeric genes involved in 
muscle contraction were upregulated in the cKO including slow-twitch muscle troponin I, 
the sacro-structural proteins desmin and Actn2, and Sypl2, a gene involved in excitation-
contraction coupling (ECC).  Additionally, biomarkers of muscle regeneration were induced 
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in the cKO such as Myh3 and Myl4 (embryonic myosin heavy and light chain isoforms) (86, 
87). We also detected elevated expression of genes necessary for muscle growth and 
development such as the myogenic regulatory factor, Myf6, the muscle hypertrophic 
regulator follistatin, and muscle associated receptor tyrosine kinase (Musk), which is 
necessary for neuromuscular junction formation (88). Moreover, changes to glucose and 
lipid metabolic genes were revealed in cKO muscle including upregulation of muscle 
glycogen synthase 1 and carnitine acetyltransferase, respectively. 
 
Table 1. Whole Genome Array. Key genes upregulated in soleus muscles from 10 month 
old Mbtps1 cKO and control littermates as assessed for expression by whole genome array. 
N=3 mice per group. Data provided by Dr. Jeff Gorski. 
 
 
 
Gene Description 
Fold change 
 (cKO vs 
control) 
ANOVA 
p-value 
(cKO vs. 
Control) 
Actn2 actinin alpha 2 1.14 0.02035 
Crat carnitine acetyltransferase 1.22 0.00709 
Des desmin 1.18 0.01804 
Fst follistatin 1.7 0.02098 
Gsk3a glycogen synthase kinase 3 alpha 1.23 0.03052 
Gys1 glycogen synthase 1, muscle 1.3 0.00391 
Musk muscle, skeletal, receptor tyrosine kinase 1.75 0.04724 
Myf6 myogenic factor 6 1.59 0.03623 
Myh3 myosin, heavy polypeptide 3, embryonic 1.75 0.04934 
Myl4 myosin, light polypeptide 4 1.15 0.00097 
Sypl2 synaptophysin-like 2 1.41 0.05685 
Tnni1 troponin I, skeletal, slow 1 1.21 0.03828 
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CHAPTER 4 
 
DISCUSSION 
 
 
Musculoskeletal interaction constitutes a multifaceted and complex interplay 
involving mechanical coupling as well as bi-directional biochemical signaling through the 
musculoskeletal secretome, the latter emerging as a new and exciting paradigm of tissue 
cross-regulation. In the present study we investigated two potential crosstalk pathways 
within the muscle-bone unit involving the skeletal muscle-derived exercise factor, BAIBA, 
as well as the role of the bone osteocyte-specific serine protease, MBTPS1, in bone-to-
muscle crosstalk. Our results suggest that BAIBA participates in the regulation of bone 
structure and muscle function as we show that oral supplementation of L-BAIBA reduces 
bone loss and skeletal muscle contractile decline in a mouse model of extended hind limb 
disuse. Next, we provide evidence for a novel bone-to-muscle crosstalk pathway involving 
MBTPS1 since its targeted ablation in osteocytes induced a skeletal muscle regeneration 
phenotype and enhanced skeletal muscle mass and contractile force output by 10 months 
of age.  Remarkably, the skeletal muscle-specific effects observed in these two crosstalk 
models were confined to slow-twitch soleus muscles while fast-twitch EDL muscles 
remained generally unaffected.  
The release of BAIBA from skeletal muscle has been demonstrated previously using 
in vitro cell culture as well as serum measures collected post-exercise training (46), 
however this has not been directly confirmed in fully functional whole muscle samples. 
Here we show unequivocally that isolated and functionally intact fast and slow-twitch adult 
skeletal muscles secrete BAIBA in a manner dependent on the onset of muscle contractile 
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activity. We found that contraction increased muscle-excreted BAIBA ~5 fold compared to 
uncontracted conditions (Illustration 2). A previous study showed a similar 5.2 fold 
induction in BAIBA content in gastrocnemius muscle from exercise trained mice (46).  We 
further show by LC/MS isomer profiling that BAIBA is preferentially secreted from skeletal 
muscle as the L-isomer and that this form displays bioactivity within muscle and bone 
(Illustration 2).  The identification of the preferred isomeric state of muscle-derived BAIBA 
may indicate that the reported metabolic effects of BAIBA in adipose, liver and skeletal 
muscle tissues are due to L-BAIBA-specific bioactivity. Thus, specific in vivo therapeutic 
application of L-BAIBA may afford greater potency with regard to impact on health and 
potential for treating metabolic disorders than the racemic mixture containing both L- and 
D- isomers.   
BAIBA is a known endogenous ligand of mas-related G-protein coupled receptor D 
(MRGPRD), belonging to the Mas-related gene family of G-protein-coupled receptors (89). 
MRGPRD is expressed highly in the dorsal root ganglion where it participates in in itch/pain 
neuro-sensation but is also expressed in a number of other tissues including white/brown 
adipose, brain, testis, lung, gastrointestinal tract, cardiovascular system and skeletal 
muscle (90).  Activation of MRGPRD upon ligand-binding results in a downstream increase 
in intracellular calcium concentration ([Ca2+]i) via the coupled action of the G-protein alpha 
subunit, Gq (91). L-BAIBA treatment during hind limb unloading led to enhanced contractile 
force of the soleus muscle when stimulated at the sub-optimal frequency of stimulation 
producing about 50% of maximal tetanic force (40 Hz) (Illustration 3). Muscle contractility 
elicited at high and low frequency impulse stimulation is influenced differently by 
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intramuscular factors such as Ca2+ mobilization, ECC and contractile protein interaction. 
Low frequency stimulation producing sub-optimal contractile force is highly dependent on 
alterations to calcium availability and ECC efficiency, whereas in high-frequency maximal 
force production the activation level is saturated and less prone to changes in ECC (81, 92). 
Thus, chronic stimulation of MRGPRD through BAIBA supplementation may result in 
significantly elevated baseline [Ca2+]i and increase the free Ca2+ available for contractility at 
sub-maximal frequencies of stimulation. The enhanced rate of force development at the 
sub-optimal stimulation frequency of 40 Hz (Illustration 3) in L-BAIBA supplemented soleus 
muscles further supports increased [Ca2+]i for activation of contraction. On the other hand 
we did not detect similar effects in fast-twitch EDL muscle with supplementation 
(Illustration 4). One possible explanation for these fiber-specific results involves differential 
fiber-type responsiveness to increased [Ca2+]i with slow-twitch fibers from soleus muscle 
showing a lower calcium-activation threshold for contraction relative to fast-twitch EDL 
muscle fibers (93).  It is also likely that the different metabolisms of fast and slow-twitch 
muscles played a role in the targeted effects of BAIBA. Slow twitch muscles display 
preferential oxidative metabolism and abundant mitochondria while fast muscles rely 
heavily on the glycolytic production of ATP. Mitochondria are a core site for dysfunction 
during the adaptation of muscle to unloading conditions leading to reduced mitochondrial 
density, decreased oxidative metabolic gene expression, lower respiratory capacity and 
redox imbalance. BAIBA has been shown to be an activator of genes involved in fatty acid 
oxidation which may help to boost mitochondrial function and viability during the myo-
adaptive response to disuse. Therefore, the targeted effects of BAIBA on slow-twitch soleus 
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muscle may be underscored by the intrinsic contractile properties of slow type MHC or the 
vulnerability of slow-twitch muscle plasticity to disuse. 
BAIBA treatment during hind limb unloading resulted in a higher trabecular bone 
BV/TV value compared to bones from control mice indicating that BAIBA treated animals 
had a higher bone content (Illustration 5).  This effect may be attributed to either 
suppression of bone resorption and/or stimulation of bone formation by BAIBA. 
Interestingly, BAIBA has been shown to increase mitochondrial respiration and insulin 
signaling through AMPK mediated pathway in skeletal muscle (48), adipose (27) and liver 
(31). In bone, AMPK acts as a negative regulator of osteoclast differentiation by inhibiting 
RANKL signaling and is therefore a prominent figure in the regulation of bone health and 
structural homeostasis. Ablation of AMPK catalytic activity within bone resulted in 
increased remodeling and ultimately bone loss (94). On the other hand, AMPK activation in 
bone results in an anabolic response (95). Therefore, the bone protective effects of BAIBA 
are likely mediated through AMPK signaling by suppressing bone loss during hind limb 
disuse. These findings further supports the existence of an exercise-dependent hormonal 
pathway in the regulation of bone health involving circulating BAIBA derived from 
contracting skeletal muscle.  
Next, we investigated bone-to-muscle crosstalk. We specifically probed the 
contribution of the protease MBTPS1 in bone-to-muscle communication and found that 
deletion of Mbtps1 in bone osteocytes resulted in an age-related slow-twitch muscle 
phenotype involving increased soleus muscle mass and enhanced force generation. We 
show that this muscle phenomenon is absent in 12-weeek old (3-month) soleus muscles 
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(Illustration 10) indicating that the cKO-induced transformation occurs after this 
developmental time point. Apart from a 25% increase in stiffness (data not shown), bone 
was essentially unaltered under Mbtps1 deletion suggesting that a bone-to-muscle 
endocrine crosstalk mechanism and not altered functional coupling is responsible for the 
muscle phenotype. Surprisingly, soleus muscles from mature Mbtps1 cKO mice produced 
~30% more contractile force (mN) than control mice (Illustration 7) even when normalized 
to the size dimensions of the muscle (N/cm2) (Illustration 7). These findings indicate that 
additional protein and metabolic alterations which are independent of muscle size are 
contributing to contractile force development in the cKO muscle. Upon evaluation of soleus 
muscle gene expression profiles by whole genome array we found altered expression of 
genes related to muscle contraction in the cKO (Table 1), namely in Actn2, desmin, Musk  
and Sypl2 expression.  ACTN2 (α-actinin 2) is an actin-binding protein family member and is 
a major structural component of the Z-disc where it anchors actin-thin filaments and forms 
contacts with numerous sacromeric structural proteins including titin and dystrophin aiding 
in the stabilization of the contractile apparatus during muscle contraction. ACTN2 is 
normally localized to both type-2 and type-1 muscle fibers (96) and has been found to 
increase in content inside fast and slow twitch myofibers after both  sprint-type training 
and endurance exercise in mice (97, 98) .  Desmin is the predominant intermediate 
filament protein in skeletal muscle and plays a central structural role in sarcomeric 
scaffolding at the Z-disk as well as anchoring the contractile apparatus to cytoskeletal 
domains at the sarcolemma (99).  Desmin is important for skeletal muscle structural 
integrity (100), for active and passive force transmission (101, 102) and for proper ECC 
  44   
 
(103).  MusK encodes a muscle specific receptor tyrosine kinase required for proper 
formation and maintenance of the post-synaptic neuromuscular junction (NMJ) (88).  MusK 
becomes highly expressed in differentiating myoblasts during muscle development but 
becomes substantially downregulated and localized only to NMJ sites in mature adult 
muscle (104). Inactivating mutations in MusK cause congenital myastenic syndrome which 
is characterized by severe muscle weakness and increased fatigueability due to aberrant 
ECC from the absence or degradation of NMJs (105).  NMJ activation plays an important 
role in the determination of skeletal muscle fiber type and contractile properties. Soleus 
muscles cross-innervated with neuronal components normally localized to fast twitch 
muscles display contractile properties similar to that of fast twitch muscles including 
elevated force-velocity, faster relaxation and lower relative tension at sub-optimal 
frequencies of stimulation (106). Interestingly, the latter characteristic was observed in cKO 
soleus muscles as a rightward-shifted force-frequency curve (Illustration 8) resembling that 
of a more fast-twitch muscle.  Finally, SYPL2 (synaptophysin-like 2) is a synaptophysin 
protein linked to muscular ECC dysfunction with aging (107). Mice deficient in Sypl2 display 
triad junction abnormalities, deficiencies in SR Ca2+ uptake and release, reduced force and 
increased susceptibility to fatigue (108, 109) while upregulation of Sypl2 is associated with 
improved muscle function (110). Taken together, the genetic data align with functional 
properties of cKO slow-twitch soleus muscles to suggest that enhanced structural 
fortification and force transmission, altered NMJ activity, and improved ECC could be 
collectively contributing to the functional properties cKO soleus muscle. 
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Soleus muscles from 10-month old Mbtps1 cKO mice were larger (Illustration 7) 
than control.  Interestingly, expression of follistatin, which is essential for skeletal muscle 
development and post-natal muscle hypertrophy (111), was augmented in cKO soleus 
muscles.  Follistatin is a TGF-β antagonist able to bind to and inhibit the actions of 
myostatin in vivo (112) and stimulate mTOR activity (113).  Muscles from mice with genetic 
deletion of follistatin have less mass, reduced contractile force and show compromised 
regenerative ability after injury (114). Conversely, delivery of follistatin-overexpressing 
adeno-associated virus vector to skeletal muscle groups causes profound muscle 
hypertrophy and enhanced strength (113, 115). Thus, repression of TGF-β signaling by 
follistatin in cKO soleus muscles could be ultimately responsible for to the phenotypic 
changes seen in muscle mass and force.  In cKO soleus muscles, we found a 7-fold increase 
in centralized nuclei exclusively within MHC type-1 expressing fibers (Illustration 9). 
Myonuclei are normally localized to the periphery and adjacent to the sarcolemma while 
centralized nuclei are apparent within myofibers during active muscle regeneration (116).  
Minor muscle damage caused by day to day activity normally results in a small proportion 
of active myonuclei replacement (1-2%) (117). We observed a proportion of 21.5% of cKO 
soleus myofibers displaying central nuclei (Illustration 9) while EDL muscle from the same 
animals showed only background levels (4.0%).  Importantly, these animals were not 
subjected to conditions which would result in marked muscle damage such as inclined 
treadmill running. Genetic markers of muscle regeneration were found to be upregulated 
in the soleus muscles of 10 month old cKOs including Myh3, Myl4, and Myf6 (Table 1).  
Embryonic myosin heavy chain isoforms such as Myh3 and Myl4 are expressed during 
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myofiber regeneration and fetal development, respectively (118, 119). Myf6 encodes a 
myogenic regulatory transcription factor required for satellite cell activation, proliferation, 
and determination of myogenic fate (120). Thus cKO of Mbtps1 in bone seems to be 
activating a slow-twitch muscle specific regeneration pathway.  
Although mRNA profiling may explain the altered cKO soleus muscle phenotype, it is 
unknown how slow-twitch fibers are specifically targeted in this model. There is evidence 
that regulation of myogenesis occurs differently with respect to muscle fiber-type through 
the activation of discrete fast or slow twitch muscle –producing stem cell population (121). 
Additionally, primary satellite cells derived from soleus and EDL muscles behave differently 
within in vitro cell cultures with different proliferative and differentiation capabilities and 
responses to altered extracellular matrix compositions (122). 
The reciprocal influences of bone-muscle endocrine/paracrine crosstalk may have 
significant impacts on bone and muscle health with respect to disease and aging processes. 
Indeed, muscle and bone quality are closely related.  Sarcopenia and osteoporosis, the 
aging-related declines in muscle mass/function and bone density/strength, respectively, 
tend to occur concomitantly in the same individual (39). There is evidence that changes in 
pleiotropic genetics may play a role in musculoskeletal aging and disease which could 
affect normal secretory capacity and/or tissue responsiveness to secreted musculoskeletal 
factors (123, 124). Muscles and bone also influence each other in terms of tissue repair.  
Bone fracture healing is greatly improved with the application of vascularized muscle tissue 
flaps within the fracture area suggesting that local release of growth factors and/or stem 
cells from muscle may participate in normal healing and repair mechanisms (125-127).  
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Therefore, the development of efficacies which target musculoskeletal biochemical 
commutation mechanisms may harbor great promise for treating a variety of 
musculoskeletal dysfunction in aging and disease. 
In summary, with regards to muscle-to-bone or muscle-muscle crosstalk,  we found 
that L-BAIBA is released from contracting skeletal muscles and that supplementation at 
100mg/kg/day in mice during two weeks of hind limb unloading resulted in increased slow-
twitch soleus muscle contractile force and rate of force development and reduced loss of 
trabecular bone content. These results highlight slow-twitch specific contractile effects of L-
BAIBA and implicates L-BAIBA in muscle-to-bone endocrine crosstalk as an exercise 
metabolite that regulates bone structure.  Next, with regards to bone-to-muscle crosstalk, 
we found that deletion of the protease, Mbtps1, in bone osteocytes resulted in a slow-
twitch muscle phenotype characterized by actively regenerating type 1 myofibers and 
increased soleus muscle specific force and mass.  Soleus muscle gene expression data 
correlated with observed structural and functional impacts. Bones were essentially normal 
in cKO mice indicating that musculoskeletal mechanical coupling is normal and that the 
effects in muscle are likely mediated by a novel Mbtps1-dependent bone-to-muscle 
endocrine crosstalk mechanism.  Finally, these findings collectively underscore the humoral 
component and co-dependence of musculoskeletal health and physiology and its 
implications in aging and disease. 
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